Liberate Bio

Boston, United States

Liberate Bio develops non-viral delivery technologies for nucleic acid cargoes, aiming to address genetic disorders.

$31.0M raised

Oct 2025

Seed

Top Investors

Khosla Ventures

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Liberate Bio raised?

Liberate Bio has raised $31.0M in total funding. The most recent round was Seed. The last funding was announced in October 2025.

Who are Liberate Bio's investors?

Liberate Bio's investors include Khosla Ventures.

Where is Liberate Bio headquartered?

Liberate Bio is headquartered in Boston, United States.

What does Liberate Bio do?

Liberate Bio develops non-viral delivery technologies for nucleic acid cargoes, aiming to address genetic disorders.

What stage is Liberate Bio at?

Liberate Bio is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated October 15, 2025.

MLA

"Liberate Bio — Funding & Investors." VCBacked, October 15, 2025, https://www.vcbacked.co/company/liberate-bio. Accessed June 4, 2026.

APA

VCBacked. (2025). Liberate Bio — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/liberate-bio

Wikipedia (cite web)

{{cite web |title=Liberate Bio — Funding & Investors |url=https://www.vcbacked.co/company/liberate-bio |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated October 15, 2025.